Work

Serum tumor marker (STM) decline rates during high-dose chemotherapy (HDCT) to predict outcome for germ cell tumor (GCT) patients (pts).

Year: 2012

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2012.30.15_suppl.4532

Authors: Darren Richard Feldman, Martin Henner Voss, Xiaoyu Jia, Lindsay Joy Van Alstine, Sujata Patil, Patricia Fischer, Joel Sheinfeld, George J. Bosl, Robert John Motzer

Institution: Memorial Sloan Kettering Cancer Center

Language: English

Topic: Testicular diseases and treatments

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2502539977

Cites:

Cited by: 3

Related to: 10